In generally healthy adults, how does melatonin affect sleep architecture, including sleep onset latency, sleep efficiency, REM sleep proportion, and deep (slow‑wave) sleep?

Melatonin's Impact on Sleep Architecture

Melatonin produces modest but clinically meaningful improvements in sleep onset latency (reducing it by approximately 4-15 minutes) and sleep efficiency (increasing it by 2-3%), with minimal to no effect on total sleep time, REM sleep, or slow-wave sleep in generally healthy adults. 1

Sleep Onset Latency

The most consistent benefit of melatonin is reducing the time it takes to fall asleep, though the magnitude varies by population:

• General adult population: Meta-analysis shows a reduction of approximately 4 minutes (95% CI: 2.5-5.4 minutes) 2
• Older adults (≥55 years): More substantial benefit with reductions of 8.9-19.1 minutes, particularly in those aged 65-80 years 1
• Younger adults under 55: Minimal to no clinically significant improvement 1

The American Academy of Sleep Medicine guideline notes this effect "falls below clinical significance" in most populations, with low quality evidence due to imprecision and publication bias 1.

Sleep Efficiency

Melatonin modestly improves sleep efficiency (the percentage of time in bed actually spent asleep):

• Increase of 2.2-3.1% in meta-analyses 1, 2
• Individual studies show improvements from baseline sleep efficiency of 77% to 83% with melatonin 3
• The effect is circadian-phase dependent: melatonin works best when sleep occurs outside the normal circadian night (when endogenous melatonin is absent) 3

Total Sleep Time

The impact on total sleep duration is minimal and clinically insignificant:

• Increase of only 12.8-13.7 minutes on average 2
• Most individual studies found increases of 2.2-23.8 minutes, with very low quality evidence 1
• A recent 2026 trial showed 23.83 minutes increase versus a 39.25-minute decrease with placebo, suggesting benefit primarily in preventing sleep deterioration 4

Wake After Sleep Onset (WASO)

Evidence is contradictory and of very low quality:

• Some studies show a paradoxical increase in WASO (+8.5 minutes) 1
• A 2026 trial showed improvement (−14.92 minutes with melatonin vs. +24.71 minutes with placebo) 4
• Overall, no reliable benefit can be established 1

REM Sleep and Slow-Wave Sleep Architecture

Melatonin does not significantly alter sleep stage architecture in most circumstances:

• REM sleep: Only higher doses (≥5 mg) show increased REM sleep 5, but standard doses (0.3-3 mg) show no significant effect 3
• Slow-wave sleep (deep sleep): No significant changes observed 3
• Sleep spindles: Some evidence suggests increased sleep spindle activity during daytime sleep after melatonin, mimicking nocturnal sleep patterns 5

Critical Dosing and Timing Considerations

The evidence reveals important nuances about optimization:

Dose-Response Relationship

• Optimal dose appears to be 4 mg/day based on dose-response meta-analysis 6
• Standard 2 mg doses show minimal effects 1
• Very low doses (0.1-0.3 mg) may be as effective as higher doses for sleep efficiency 3

Timing of Administration

• Administer 1-3 hours before desired bedtime (not the commonly used 30 minutes) 7, 6
• Earlier administration (around 6 PM for a typical bedtime) optimizes circadian rhythm regulation 7
• Meta-regression shows time between administration and sleep is a significant predictor of efficacy (β = -0.16, p = 0.023) 6

Formulation Matters

• Sustained-release formulations show better efficacy than immediate-release 1, 4
• Fast-release may work for sleep onset but sustained-release provides better overall sleep quality 1

Common Pitfalls to Avoid

1. Using too low a dose too close to bedtime: The typical over-the-counter recommendation of 2 mg taken 30 minutes before bed is suboptimal 6

2. Expecting dramatic improvements: The effects are modest—minutes, not hours—and primarily benefit sleep initiation rather than maintenance 1, 2

3. Assuming it works for everyone: Benefits are most pronounced in:

   • Older adults (≥55 years) 1
   • Those with circadian rhythm disruption 3
   • Individuals with low endogenous melatonin production 1

4. Overlooking the lack of effect on sleep architecture: Melatonin does not increase deep sleep or substantially alter REM sleep at standard doses 5, 3

Quality of Evidence Limitations

The American Academy of Sleep Medicine guideline consistently rates the evidence as low to very low quality due to:

• Significant imprecision in effect estimates
• Potential publication bias
• Heterogeneity in study populations and formulations
• Small sample sizes 1

In clinical practice, melatonin's role is best understood as a mild sleep-promoting agent that primarily facilitates sleep initiation through circadian rhythm regulation, rather than as a medication that fundamentally alters sleep architecture or provides robust improvements in sleep maintenance.